Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation ‐wide multicenter study
ConclusionTaken together, ABC remained the mainstay of breast cancer treatment, especially in neo and adjuvant therapy. ABC was mainly used as a combination therapy, and the correlation between influencing factors and ABC choice varied during different settings, indicating the preference and different perspectives of medication considered by medical oncologists regarding the use ABC in China.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Fengzhu Guo,
Zongbi Yi,
Wenna Wang,
Yiqun Han,
Pei Yu,
Su Zhang,
Quchang Ouyang,
Min Yan,
Xiaojia Wang,
Xichun Hu,
Zefei Jiang,
Tao Huang,
Zhongsheng Tong,
Shusen Wang,
Yongmei Yin,
Hui Li,
Runxiang Yang,
Huawei Yang,
Yuee Teng,
Tao Sun Tags: RESEARCH ARTICLE Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | China Health | Ductal Carcinoma | Epidemiology | Mastectomy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Oral Cancer | Palliative | Study